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Abstract In the course of chronic kidney disease (CKD)
the intracellular erythrocyte calcium (Cai
2+) level increases
along with the progression of the disease. The decreased
activity of Ca
2+-Mg
2+-dependent ATP-ase (PMCA) and its
endogenous modulators calmodulin (CALM), calpain
(CANP), and calpastatin (CAST) are all responsible for
disturbed calcium metabolism. The aim of the study was to
analyze the activity of PMCA, CALM, and the CANP-
CAST system in the red blood cells (RBCs) of hemodia-
lyzed (HD) children and to estimate the impact of a single
HD session on the aforementioned disturbances. Eighteen
patients on maintenance HD and 30 healthy subjects were
included in the study. CALM, Cai
2+ levels and basal PMCA
(bPMCA), PMCA, CANP, and CAST activities were
determined in RBCs before HD, after HD, and before the
next HD session. Prior to the HD session, the level of Cai
2+
and the CAST activity were significantly higher, whereas
bPMCA, PMCA, and CANP activities and the CALM level
were significantly lower than in controls. After the HD
session, the Cai
2+ concentration and the CAST activity
significantly decreased compared with the basal values,
whereas the other parameters significantly increased,
although they did not reach the levels of healthy children.
The values observed prior to both HD sessions were
similar. Cai
2+ homeostasis is severely disturbed in HD
children, which may be caused by the reduction in the
PMCA activity, CALM deficiency, and CANP-CAST
system disturbances. A single HD session improved these
disturbances but the effect is transient.
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Introduction
Chronic kidney disease (CKD) involves intracellular
calcium (Cai
2+) accumulation in numerous tissues, which
leads to intensification of various clinical symptoms. With
respect to red blood cells (RBCs), these features are
related to increased deformation and morphological
c h a n g e si ne r y t h r o c y t e s ,w h i c hi nt u r ns h o r t e n st h e i rl i f e
span, and hence increases anemia.
Normal calcium level in erythrocytes is assured by the
influx of those ions through the cell membrane and active
efflux outside the cell by an energy-dependent calcium
pump: Ca
2+-M g
2+-dependent–ATP-ase (PMCA), plasma
membrane Ca
2+-Mg
2+-transporting adenosine triphospha-
tase: ATP-ase 3.6.1.38. Human PMCA is encoded by at
least four genes (phenotypes denoted as PMCA 1–4) [1, 2].
PMCA 4b is the main type in mature RBC. The activity of
the pump is modified by a network of protein factors—
calmodulin (CALM) and the calpain-calpastatin system
(CANP-CAST) in particular [3, 4].
Our earlier studies have revealed that children and
adolescents with CKD stages 2–4 are characterized by a
reduced PMCA activity in erythrocytes accompanied by a
CALM deficit and disturbances in the CANP-CAST system
[5, 6]. The changes result in a high intracellular calcium
level. There are no studies concerning children on renal
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stage kidney disease (ESKD), reduced PMCA activity and
calcium accumulation in erythrocytes were observed, both
in patients on hemodialysis (HD) and peritoneal dialysis as
well [7–10]. However, the data concerning the impact of
the HD session on these disturbances are rare and the
results of the few studies are not uniform and do not
involve endogenous modulators of PMCA activity [7–9].
The aim of our study was to analyze the activity of PMCA,
CALM, and the CANP-CAST system in erythrocytes of
hemodialyzed children and to estimate the impact of a single
HD session on the above-mentioned disturbances.
Subjects and methods
Patients
Eighteen hemodialyzed children from the Dialysis Unit of
the Paediatric Nephrology Department, Medical University
in Wrocław, were enrolled in the study. The control group
consisted of 30 healthy, age-matched subjects, hospital-
ized because of nocturnal enuresis, with normal kidney
function. Table 1 shows the biochemical characteristics of
the groups examined. The reasons for ESRD were as
follows: chronic glomerulonephritis (10 patients), chronic
pyelonephritis (6 patients), and abnormalities of the
urinary tract (2 patients).
The duration of HD therapy ranged from 5 months to
48 months (mean: 15±4 months). Dialysis was carried out
for 4 h three times weekly, using polysulphone membranes
and dialysate with bicarbonate, calcium 1.5 mmol/L,
potassium 2 or 3 mmol/L, blood flow 150–300 ml/min.
Eleven patients were treated effectively with antihyper-
tensive drugs (calcium channel blockers—nifedipine
[Polfa-Grodzisk, Grodzisk, Poland], angiotensin-
converting enzyme inhibitors, beta-blockers). Other drugs
used were: erythropoietin, vitamin D3 analogs, vitamins C,
B complex, folic acid, iron, and ranitidine hydrochloride.
All CKD patients were kept on a phosphate-poor diet
(phosphate intake did not exceed 500–800 mg/day) and treated
with compounds binding phosphate in the intestine (calcium
carbonate at a dosage of 35–200 mg/kg/day). The doses of
these therapeutic agents were individualized, so as to maintain
the serum concentrations of phosphate at 4.5–5.52 mg/dl and
calcium at 8.8–10.8 mg/dl. Dietary calcium intake was defined
as 500–6 0 0m go fe l e m e n t a r yc a l c i u mp e rd a y .
Laboratory investigations
The following parameters were determined in the serum:
inorganic phosphate (Pi), total calcium (t-Ca), creatinine
(cr), urea, intact parathormone (iPTH); whereas Cai
2+,
CALM concentrations, and activities of PMCA, basal
PMCA (bPMCA), CANP, and CAST were assessed in red
blood cells.
Serum Pi, and t-Ca were tested by the direct potentiom-
etry method using ion-selective ISE electrodes in the
automatic analyzer Konelab (bioMérieux, Craponne,
France) with the reference ranges: 8.80–10.80 mg/dl and
4.5–5.52 mg/dl respectively. Serum creatinine was deter-
mined by the Jaffe method (reference range: 0.3–1.0 mg/dl)
and urea was measured using the enzymatic-colorimetric
method (reference range: 10.00–45.00 mg/dl).
Intact parathormone (iPTH) was estimated by the
immunoenzymatic ELISA microassay of the solid phase
from Roche Diagnostic (Warsaw, Poland) on Immulite
2000 apparatus (reference range: 11–67 pg/ml).
Alcohol dehydrogenase (yeast), casein, CANP I from
human erythrocytes, DTT (dithiothreitol), PBS and Ultra Gel
AcA34 were purchased from Calbiochem (Warsaw, Poland)
and the remaining reagents and materials from Sigma-Aldrich
(Poznan, Poland).
In the control group, morning blood samples were
obtained from fasted children from the antecubital vein in
the sitting position, whereas in hemodialyzed patients blood
samples were collected from the arterial line immediately
prior to HD and immediately after the HD session. The
third blood sample was obtained before the following HD
session (pre-hemodialysis), which was performed 48 h after
the first session. Serum was separated within 1–3ho f
blood collection and the samples were stored at −70°C.
Hemodialyzed Control p
Gender (male and female) 10/8 17/13 NS
Age (years) 16.1±2.0 14.7±2.7 <0.001
iPTH (pg/ml) 233±59 46.69±9.22 <0.001
Pi (mEq/l) 5.97±0.65 4.95±0.33 <0.001
t-Ca (mg/dl) 9.05±0.78 9.70±0.63 <0.01
cr (mg/dl) 7.29±0.92 0.81±0.15 <0.001
GFR (ml/min/1.73 m) <10 ml 129±8.7
Kt/V 1.25±0.04
Table 1 Selected clinical and
biochemical parameters in
investigated patients
NS non-significant
2502 Pediatr Nephrol (2010) 25:2501–2507All parents of younger children and adolescents enrolled
in the study gave their informed consent for the procedures
performed. The investigation protocol was approved by the
local ethics committee.
Preparation of red blood cells (RBCs)
The preparation of RBCs was performed according to
Beutler et al. [11]. The methodology was described in detail
in our previous study [5].
Measurement of PMCA and bPMCA activity
in the suspension of erythrocyte membranes
Hemoglobin was removed from erythrocyte hemolysates
according to the Lehotsky et al. method [12]. The
methodology concerning the PMCA and bPMCA activity
assessment was described in detail in our previous study
[5]. bPMCA activity measurement is based on its ability to
hydrolyze ATP to ADP and Pi.P i was determined using the
colorimetric method of Fiske and Subbarow [13].
The intra-assay (within 1 day) and inter-assay (between
different days) coefficients of variation (%CV) for PMCA at
the quantification limit were <8.5% and <6.7% respectively.
Determination of CALM
Calmodulin concentration in erythrocyte hemolysate (in core
extract) was assessed with the modified spectrophotometric
method established by Garg et al. [14]. CALM concentration
was measured according to the methodology described in
detail in our previous study [5].
Determination of Cai
2+ in human erythrocytes
The measurement of Cai
2+ was conducted in intact
erythrocytes according to Soldati et al. [15] with minor
modifications (after incubation with Fura-2, erythrocytes
were diluted with HBS solution without Ca
2+ content).
Fluorescence measurements were conducted on Perkin
Elmer LS50 spectrometer, and calculations were performed
according to Grynkiewicz et al. [16] and Poenie et al. [17].
The determination of free cytoplasmic calcium in human
erythrocytes was described in detail in our study [5].
The intra-assay and inter-assay %CV for Cai
2+ at the
quantification limit are 4.5 and 2.0% respectively.
Determination of CANP and CAST activities
Hemoglobin was removed from erythrocyte hemolysates
according to the method of Lehotsky et al. [12]. The
activities of CANP and CAST were measured by the
method described by Kosower et al. [18].
Determination of protein concentration
Protein concentration was measured using the method of
Bradford et al. [19] with bovine albumin as a standard.
Statistical analysis
Results are expressed as mean values and standard
deviation: x±SD. A repeated variance analysis (repeated
ANOVA) and a post-hoc test (LSD test) were applied in
order to compare means between intervals. Comparisons
between the study group and controls were performed using
Student’s t test. The associations between variables were
analyzed by Pearson correlation coefficients. A p value of
less than 0.05 was considered statistically significant.
Results
Cai
2+ (nmol/l)
In HD patients the intracellular Cai
2+ concentrations were
significantly higher than in controls, regardless of the
timing of blood sampling. A significant decrease in Cai
2+
concentration was observed after the HD session compared
with the basal values (152.33±11.80 nmol/l vs 58.94±
4.45 nmol/l; p<0.001), whereas the values observed prior
to both HD sessions were similar.
Serum t-Ca levels before and after HD were significantly
different (p<0.05). There was no significant difference
between the levels of t-Ca in patients after HD and children
from the control group.
No correlation was found among Cai
2+, t-Ca , Pi, and
iPTH.
The mean Cai
2+ concentrations in RBCs of the investi-
gated groups are shown in Fig. 1.
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Fig. 1 The mean values of intracellular calcium (Cai
2+) concen-
trations in the red blood cells of the groups investigated
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Despite a significant increase in the PMCA activity after
the first HD session (1.22±0.28 μmol/Pi/mg/min vs 2.55±
0.31 umol/Pi/mg/min; p<0.001), its concentration before
the second one decreased to the values similar to those
observed before the first HD session. However, the PMCA
activity remained at all times significantly lower in the
study population than in the controls.
The mean values of PMCA activity in RBCs of the
groups investigated are shown in Fig. 2.
bPMCA (umol/PI/mg/min)
TheHDsessionhadnoeffectonbPMCA,asopposedtoPMCA.
The activity of bPMCA measured at different time points in
hemodialyzed children showed no statistical differences and
remained significantly lower than in healthy children (p<0.001).
The mean values of bPMCA activities in RBCs of the
groups investigated are shown in Fig. 3.
CAST (U/mg)
Calpastatin (CAST) activity was significantly higher in HD
subjects compared with controls, regardless of the timing of
sampling. After the HD session, CAST activity decreased
significantly in comparison to the basal values (28.58±
2.11 U/mg vs 64.90±3.76 U/mg; p<0.001). However, the
activity increased again before the following session and
was significantly higher than prior to the previous one
(69.93±3.04 U/mg vs 64.90±3.76 U/mg; p<0.001).
The mean CAST activities in the RBCs of the groups
investigated are shown in Fig. 4.
CANP (U/mg)
Prior to the HD session, CANP activity was significantly
lower than in the control group (28.37±3.91 U/mg vs
44.13±4.23 U/mg; p<0.001). However, the activity
increased after the HD session and was not only
significantly higher than initially, but also in comparison
to the controls. Prior to the next HD session CANP
activity was comparable to the value observed before the
previous one.
The mean CANP activities in the RBCs of the groups
investigated are shown in Fig. 5.
CALM (mg/l)
Calmodulin concentration was significantly lower in the
study group prior to HD and after the HD session compared
with the controls. However, a transient significant increase
in the concentration of CALM was observed after the HD
session, compared with the values from before HD. There
was no significant difference in CALM levels before each
HD session.
The mean CALM activities in the RBCs of the groups
investigated are shown in Fig. 6.
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Fig. 3 The mean values of basal PMCA (bPMCA) activity in the red
blood cells of the groups investigated
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Fig. 4 The mean values of calpastatin (CAST) activity in the red
blood cells of the groups investigated
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Fig. 2 The mean values of Ca
2+-Mg
2+-dependent ATP-ase (PMCA)
activity in the red blood cells of the groups investigated
2504 Pediatr Nephrol (2010) 25:2501–2507Discussion
Not surprisingly, the concentration of intracellular calcium
in the red blood cells of children and adolescents on long-
term hemodialysis was significantly higher in comparison
to healthy children. Similar disorders were observed in
adults with ESRD on maintenance HD and on continuous
ambulatory peritoneal dialysis [7, 8, 20]. Calcium accumu-
lation in erythrocytes has negative consequences, as it leads
to the membrane deformation of RBCs and increased
osmotic fragility. These disorders, in turn, result in
morphological changes of erythrocytes, mainly echino-
cytes, and reduction of their lifetime, which intensifies
anemia, which accompanies uraemia [10, 20, 21]. Increased
calcium level in erythrocytes is undoubtedly caused by
disturbed balance between Ca
2+ influx into the cell and its
efflux from the cell. Increased erythrocyte membrane
permeability for calcium in patients with ESRD was proven
many years ago [10, 20, 21]. It was found that the Cai
2+
level was twice as high as in healthy subjects, which led to
the conclusion that pore-forming toxins could be responsi-
ble for this phenomenon. Parathormone could be one of the
toxins that intensify calcium influx into the cell [7, 22].
However, no direct correlation between these parameters
was found in hemodialyzed adults [7, 10]. On the other
hand, such a correlation was observed by Karapati et al.
with regard to polymorphonuclear leukocytes (PMNs) [22].
The authors have shown that after iPTH decrease following
parathyroidectomy, the calcium level in PMNs returns to
normal values [22]. All children in our study had features of
hyperparathyroidism, which might have been one of the
reasons for increased calcium influx into erythrocytes.
Increased Cai
2+ level in erythrocytes may also result from
reduced PMCA activity, which was documented for both
children and adults with CKD treated conservatively, as
well as in adults on renal replacement therapy [5, 6, 10].
Results of the present study are compatible with the above
observations. Activity of basal and CALM-stimulated
PMCA was significantly lower than in the control group.
The pump activity may be indirectly influenced by external
factors, but its endogenous protein modulators play the
main role. In our previous study, we observed that CALM
deficit appears as early as CKD stages 2–4 and it increases
along with CKD progression [5]. The aim of the present
study was to analyze the impact of a single HD session on
CALM and the CANP-CAST system and, if there is one,
how long the effect lasts.
We have shown that the intracellular calcium concentra-
tion after dialysis is lower than before dialysis, although it
remains significantly higher than in the control group.
These results are comparable with those obtained by other
authors [7, 8, 23, 24]. The above-mentioned phenomenon
may be caused by increased PMCA activity, which in turn
is stimulated by the CANP-CAST system. Contrary to our
findings and those of Yang, Gafter et al. observed that the
calcium level in erythrocytes was similar before and after
HD sessions [8, 24]. These differences may result from the
different dialysis techniques used. Subjects studied by these
authors were dialyzed on less biocompatible dialysate
(octane) and it may be presumed, given the year of the
study (1989), that the membranes were less biocompatible
too (no data in the publication) [8].
In the present study, we have shown that the effect of a
reduced Cai
2+ level after single HD session is transient, as
both the intracellular calcium level and PMCA activities
before the second HD session were similar to the values seen
before the previous one. Aside from biological modulators,
PMCA activity may also be influenced by external factors,
such as pore-forming toxins. So far, the following plasma
toxins in erythrocyte hemolysates have been shown to act as
PMCA inhibitors: dimethylguanosine, phenylethylamine,
phenyl acid, and para-hydroxy-hippuric acid [25–28]. The
low lipophilicity of these factors limits their activity within
the cell. Therefore, their influence on the activity of the
intracellular system that we studied is questionable.
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CALM level results in permanent PMCA stimulation and
keeps the enzyme in the "open state" conformation [29, 30].
This allows maintaining PMCA activity, regardless of the
pulsatile changes in the intracellular calcium concentration.
The present study has revealed a significantly reduced
CALM concentration before the HD session. CALM level
as well as PMCA activity both significantly increased after
the HD session, but did not reach normal values. This
effect, similar to calcium pump activity, was transient,
which indicates that CALM deficit plays an important role
in PMCA deactivation. However, we have not observed any
correlation between these parameters, contrary to the results
obtained from CKD children treated conservatively [5].
ModulationofPMCAactivityinerythrocytes,withCALM
deficit and excessive calcium accumulation, is supported by
other endogenous modifiers, such as Ca-dependent kinases,
caspases, and the CANP-CAST system. According to
Pontremoli et al., increased CANP activity is the last line of
defense against excessive cytotoxic concentration of Cai
2+
accompanied by CALM deficit [31]. Activity of the CANP-
CAST system is sensitive to changes in intracellular calcium
level and dependent on reversible phosphorylation by
specific kinases and phosphatases. Multi-stage sequential
CANP activation begins with the appearance of a high local
concentration of Cai
2+. Then, CAST dissociation takes place.
CANP undergoes autolysis and its shortened molecules with
protease activity begin to attack proteins both in the
cytoplasm and the cellular membrane, including PMCA. In
consequence, the molecules of native and shortened CANP
affect PMCA and increase the number of shortened and still
active calcium pump molecules.
In our studies, CANP activity was significantly lower before
hemodialysis and was almost 2.5 times higher after the HD
session. However, it did not reach normal values. This effect
was also transient. CANP activity is related to its endogenous
inhibitor—CAST. In comparison to controls, CAST activity in
dialyzed patients was significantly higher before HD and it was
normalized partially after the session, indicating a reduced
number of active molecules, which may have resulted from
digestion by active caspases in erythrocytes.
Typical features of chronic kidney disease, such as
oxidative and carbonyl stress, accompanied by the appear-
ance of uremic toxins in plasma, leads to structural changes
in the membrane of erythrocytes and other cells. Persisting
high calcium concentration in erythrocytes, both before and
after the HD session, leads to scramblase stimulation and in
consequence to the appearance of phosphatidylserine
outside the erythrocyte membrane.
We are aware of the study limitations that arise from the
potential impact of the therapy. According to some authors,
antihypertensive drugs (calcium channel blockers,
angiotensin-converting enzyme inhibitors) have a tendency
to reduce calcium levels with a concomitant drop in blood
pressure [32, 33].
We have used nifedipine, a blocker of the membrane
voltage-dependent cation channel present mainly in excitable
cells. They are also encountered in erythrocytes, among other
channels that transport CAST
2+ into the cells, such as CAST
2+
channels, unselective cation channels TRPC6 or vanade
induced CAST
2+ entry pathway. In 11 of our patients the
anti-hypertensives were used with good therapeutic effect, but
the concentration of intracellular calcium was still increased.
Vitamin D3 analogs had virtually the same effect. There are no
studies investigating their impact on the erythrocyte Cai
2+
level, but it has been documented that 25(OH)D3 supplemen-
tation reduced the Cai
2+ level in leukocytes [34], and most
probably the same effect may be expected with respect to
erythrocytes.
Irrespective of the drugs used, the intracellular calcium
was increased in all the patients examined. Therefore, even
though the drugs might have influenced the erythrocyte
Cai
2+ homeostasis, the mechanisms leading to its normal-
ization were still disturbed.
Conclusion
Children and adolescents subjected to maintenance hemo-
dialysis demonstrate a greatly disturbed intra-erythrocyte
calcium homeostasis. Significant Cai
2+ accumulation is
caused by, among others, decreased PMCA activity,
probably due to a CALM deficit, CANP-CAST system
disorders, as well as a permanent activation of calcium-
dependent erythrocyte proteolytic enzymes. A single HD
session improves these disturbances, but the effect is
transient. The results of our study suggest that daily dialysis
might be the optimal solution for maintaining the proper
calcium homeostasis. Nevertheless, such a hypothesis
remains to be verified and requires further investigations.
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